News

Filter

Current filters:

Sanctura

1 to 9 of 16 results

Allergan gets Canadian right to Sanctura

02-06-2008

Indevus Pharmaceuticals has signed a license agreement with the Canadian affiliate of USA-based Allergan,…

AllerganSancturaSanctura XRTrospiumTrospium Chloride Extended Release Capsule

Indevus' loss doubles on charges in fiscal 2007

10-12-2007

Massachusetts, USA-based Indevus Pharmaceuticals, a specialist in the acquisition, development and commercialization…

DelatestrylSancturaTestosterone EnanthateTrospium

Allergan buys Esprit Pharma for $370M in cash

27-09-2007

US drugmaker Allergan has acquired fellow USA-based Esprit Pharma for $370.0 million in an all-cash deal.…

AllerganSancturaSanctura XRTrospiumTrospium Chloride Extended Release Capsule

Indevus gets $49.9M milestone from Esprit

20-08-2007

Indevus Pharmaceuticals has received a $49.9 million milestone payment from fellow USA-based Esprit Pharma,…

SancturaSanctura XRTrospiumTrospium Chloride Extended Release Capsule

Indevus' Sanctura XR approved by US FDA

13-08-2007

The USA's Indevus Pharmaceuticals says that Sanctura XR (trospium Cl extended-release capsules) has been…

SancturaSanctura XRTrospiumTrospium Chloride Extended Release Capsule

Indevus licenses European Sanctura XR rights to Madaus

13-11-2006

The USA's Indevus Pharmaceuticals has licensed the rights to sell Sanctura XR (trospium Cl), the once-daily…

SancturaSanctura XRTrospiumTrospium Chloride Extended Release Capsule

Strong Ph III data for Indevus' Sanctura XR

17-07-2006

US drugmaker Indevus Pharmaceuticals says that Sanctura XR (trospium Cl), the once-daily formulation…

NystatinOralSancturaSanctura XRTrospiumTrospium Chloride Extended Release Capsule

Indevus closes Sanctura transaction with Esprit

11-07-2005

Indevus Pharmaceuticals of the USA has announced the closing of the previously-announced sale of marketing…

SancturaTrospium

1 to 9 of 16 results

COMPANY SPOTLIGHT

Menarini

Back to top